“Pharmacoeconomic Analysis of Cost Comparison Between Calcium Channel Blocker (CCB) and Angiotensin II Receptor Blocker (ARB) Antihypertensive Drugs in Hospitalized Hypertensive Patients at RSU Royal Prima”. 2026. JURNAL FARMASIMED (JFM) 8 (2): 1146-55. https://doi.org/10.35451/y2fhvc35.